Literature DB >> 21481783

Multiple effects of angiopoietin-2 blockade on tumors.

Claire E Lewis1, Napoleone Ferrara.   

Abstract

In this issue of Cancer Cell, Mazzieri, Pucci, and colleagues describe the marked effects of inhibiting the proangiogenic cytokine, Angiopoietin-2, on tumor angiogenesis and progression in spontaneous tumor models, as well as the proangiogenic functions of TIE2-expressing macrophages.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID： 21481783     DOI： 10.1016/j.ccr.2011.03.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  11 in total

Review 1.  Chemotherapy-induced metastasis: mechanisms and translational opportunities.

Authors:  George S Karagiannis; John S Condeelis; Maja H Oktay
Journal:  Clin Exp Metastasis       Date:  2018-01-06       Impact factor: 5.150

2.  Gln-362 of angiopoietin-2 mediates migration of tumor and endothelial cells through association with α5β1 integrin.

Authors:  Hyo Seon Lee; Seung Ja Oh; Kwang-Hoon Lee; Yoon-Sook Lee; Eun Ko; Kyung Eun Kim; Hyung-chan Kim; Seokkyun Kim; Paul H Song; Yong-In Kim; Chungho Kim; Sangyeul Han
Journal:  J Biol Chem       Date:  2014-09-18       Impact factor: 5.157

3.  Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis.

Authors:  George S Karagiannis; Jessica M Pastoriza; Lucia Borriello; Rojin Jafari; Anouchka Coste; John S Condeelis; Maja H Oktay; David Entenberg
Journal:  J Vis Exp       Date:  2019-06-26       Impact factor: 1.355

Review 4.  The emerging roles of macrophages in cancer metastasis and response to chemotherapy.

Authors:  Luis Rivera Sanchez; Lucia Borriello; David Entenberg; John S Condeelis; Maja H Oktay; George S Karagiannis
Journal:  J Leukoc Biol       Date:  2019-02-05       Impact factor: 4.962

Review 5.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

6.  Molecular mechanisms of tumor angiogenesis.

Authors:  Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Genes Cancer       Date:  2011-12

7.  Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis.

Authors:  Racheal Grace Akwii; Md Sanaullah Sajib; Fatema Tuz Zahra; Paul Tullar; Masoud Zabet-Moghaddam; Yi Zheng; J Silvio Gutkind; Colleen L Doci; Constantinos M Mikelis
Journal:  Angiogenesis       Date:  2022-02-01       Impact factor: 10.658

8.  Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia.

Authors:  Jorge Cortes; Moshe Talpaz; Hedy P Smith; David S Snyder; Jean Khoury; Kapil N Bhalla; Javier Pinilla-Ibarz; Richard Larson; David Mitchell; Scott C Wise; Thomas J Rutkoski; Bryan D Smith; Daniel L Flynn; Hagop M Kantarjian; Oliver Rosen; Richard A Van Etten
Journal:  Haematologica       Date:  2016-12-07       Impact factor: 9.941

Review 9.  Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.

Authors:  Racheal G Akwii; Md S Sajib; Fatema T Zahra; Constantinos M Mikelis
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

10.  Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.

Authors:  Virginie Deleuze; Rawan El-Hajj; Elias Chalhoub; Christiane Dohet; Valérie Pinet; Philippe Couttet; Danièle Mathieu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.